• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Biolinerx Ltd ADR (NQ: BLRX )

    0.5050 -0.0185 (-3.53%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 3, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 169,331
    Open 0.5391
    Bid (Size) 0.5355 (20)
    Ask (Size) 0.6300 (1)
    Prev. Close 0.5235
    Today's Range 0.5050 - 0.5550
    52wk Range 0.5000 - 1.930
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    BLRX Stock Earnings: BioLine Rx Beats Revenue for Q2 2024
    BLRX stock results show that BioLine Rx beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Tuesday morning! 
    Via InvestorPlace

    Performance

    YTD
    -66.99%
    -66.99%
    1 Month
    -20.23%
    -20.23%
    3 Month
    -7.61%
    -7.61%
    6 Month
    -38.68%
    -38.68%
    1 Year
    -65.17%
    -65.17%

    More News

    Read More
    Millionaire Makers: 7 Stocks You Can Buy for $2 That Can 10X by 2025
    Via InvestorPlace
    BLRX Stock Earnings: BioLine Rx Beats EPS for Q1 2024
    Via InvestorPlace
    BLRX Stock Earnings: BioLine Rx Beats EPS for Q4 2023
    Via InvestorPlace
    Earnings Preview For BioLine Rx
    Via Benzinga
    BioLine Rx Earnings Preview
    Via Benzinga
    HC Wainwright & Co. Maintains Buy Rating for BioLine Rx: Here's What You Need To Know
    Via Benzinga
    BioLineRx Ltd. (NASDAQ: BLRX) Leading the Way in Tuesday Trading Based on Percentage Gain
    Via Investor Brand Network
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Earnings Scheduled For March 26, 2024
    Via Benzinga
    Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market – A Race Worth
    Via FinancialNewsMedia
    A Preview Of BioLine Rx's Earnings
    Via Benzinga
    3 Top Penny Stocks for 5,000% Upside in 2024 and Beyond
    Via InvestorPlace
    Earnings Scheduled For November 20, 2023
    Via Benzinga
    Week In Review: Hengrui Out-Licenses Next-Gen PARP1 To Merck KGaA For $1.7 Billion
    Via Talk Markets
    3 Tech Stocks That Wall Street Loves More Than Nvidia
    Via InvestorPlace
    3 Top Penny Stocks to Make You a Millionaire in 5 Years
    Via InvestorPlace
    BioLineRx Touts Encouraging Data From Therapy Trial For First Line Pancreatic Cancer
    Via Benzinga
    Unity Software To Rally Around 60%? Here Are 10 Other Analyst Forecasts For Friday
    Via Benzinga
    Earnings Scheduled For August 30, 2023
    Via Benzinga
    3 Cheap Biotech Stocks That Smart Investors Will Snap Up Now
    Via InvestorPlace
    3 Smart Penny Stocks with Huge Potential
    Via InvestorPlace
    The 3 Most Undervalued Biotech Stocks to Buy Now: June 2023
    Via InvestorPlace
    Earnings Scheduled For May 24, 2023
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.